HBsAg seropositive status and survival after renal transplantation: Meta-analysis of observational studies

Fabrizio Fabrizi, Paul Martin, Vivek Dixit, Fasiha Kanwal, Gareth Dulai

Research output: Contribution to journalArticle

Abstract

The natural history of hepatitis B virus (HBV) infection after renal transplantation (RT) remains unclear. We conducted a systematic review of the published medical literature on the impact of HBV surface antigen (HBsAg) seropositivity on survival of RT recipients. We used the random effects model of DerSimonian and Laird to generate a summary estimate of the relative risk for mortality and graft loss in HBsAg positive RT recipients across the published studies. We identified six observational studies (6050 unique patients); all of them being cohort, retrospective studies. Pooling of study results demonstrated that HBsAg in serum was an independent and significant risk factor for death after RT; the summary estimate for relative risk was 2.49 with a 95% confidence interval (95% CI) of 1.64-3.78. A test for homogeneity of the relative risk across the studies gave a p-value of

Original languageEnglish
Pages (from-to)2913-2921
Number of pages9
JournalAmerican Journal of Transplantation
Volume5
Issue number12
DOIs
Publication statusPublished - Dec 2005

Keywords

  • HBV surface antigen (HBsAg)
  • Hepatitis B virus (HBV)
  • Meta-analysis
  • Mortality
  • Observational studies
  • Renal transplantation (RT)

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'HBsAg seropositive status and survival after renal transplantation: Meta-analysis of observational studies'. Together they form a unique fingerprint.

  • Cite this